Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Nazzal Bsoul"'
Autor:
Kamal F Akl, Abdul Karim Qudah, Abdalla Awidi, Mohammad Jaber Suleiman, Nidaa Ababneh, Nazzal Bsoul, Ahmad Magablah
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 25, Iss 6, Pp 1304-1307 (2014)
Externí odkaz:
https://doaj.org/article/b54f1175b7994fe091b9fe663fc9098b
Autor:
Abdulhameed Ghabkari, Ahmad Magableh, Asem Alkhateeb, Yazan Haddad, Khaldon Bodoor, Nazzal Bsoul, Mohammad Dowairi, Abdullah Al-Abbadi
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 15:75-84
Aberrant DNA methylation of tumor suppressor genes has been reported in all major types of leukemia with potential involvement in the inactivation of regulatory cell cycle and apoptosis genes. However, most of the previous reports did not show the ex
Autor:
Abdul Karim Qudah, Nazzal Bsoul, Ahmad Magablah, Kamal F. Akl, Nidaa A. Ababneh, Abdalla Awidi, Mohammad Jaber Suleiman
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 25, Iss 6, Pp 1304-1307 (2014)
Publikováno v:
Platelets. 20:297-301
We examined platelet aggregation in platelet-rich plasma (PRP) and in whole blood in nine patients with Thrombasthenia Glanzmann (TG). In PRP, aggregation was measured by monitoring the changes in light absorbance that occurred in response to adenosi
Autor:
Eyad Arafat, Abdalla Awidi, Ayed O. Ayed, Lena Marie, Mohammad Dweiri, Ahmad Magablah, Mohammad Ramahi, Nazzal Bsoul, Mohammad Bishtawi, Razan Mefleh
Publikováno v:
Leukemia Research. 34:1573-1575
One hundred and three patients with Philadelphia chromosome or BCR-ABL positive chronic myeloid leukemia (CML) in chronic phase who were on oral imatinib were included in this study. The study aimed to assess the relationship between imatinib trough
Autor:
Zaid Tamimi, Nazzal Bsoul, Ghazi Mohammad Al Edwan, Jamal K. Almasad, Faleh A. Sawair, Zaid H. Baqain, Abdalla A Abbadi
Publikováno v:
Annals of the Royal College of Surgeons of England. 92(6)
INTRODUCTION We describe our experience with oncology patients on a frequent dosing schedule of intravenous (i.v.) bisphosphonates at the Jordan University Hospital (JUH). PATIENTS AND METHODS Patients treated by i.v. bisphosphonates in the medical o
Autor:
M. Falah, S. Fauori, S. Swaidan, Razan Mefleh, M. Bishtawi, E. Arafat, Nazzal Bsoul, Dana Alhattab, M. Ramahi, M. Barqawi, Ahmad Magablah, M. Dweiri, Abdelhalim Awidi, E. Haddadeen, B. Tarawneh
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 16(1)
Summary. Haemophilia A (HA) is an X-linked recessive bleeding disorder caused by mutations in the factor VIII gene (F8), which encodes factor VIII (FVIII) protein, a plasma glycoprotein, that plays an important role in the blood coagulation cascade.
Publikováno v:
Medical principles and practice : international journal of the Kuwait University, Health Science Centre. 18(5)
Objective: Study of the disease patterns and clinical evaluation of myelodysplastic syndrome (MDS). Subjects and Methods: A retrospective analysis was carried out on 85 patients, with MDS who were followed up over a period of 23 years at Jordan Unive
Publikováno v:
Journal of thrombosis and thrombolysis. 28(3)
Venous Thrombo-Embolism (VTE) is a serious complication in hospitalized patients but can be preventable. This prospective study addresses risk factors assessment and the use of heparin in this population. About 2,496 non pediatric patients were admit
FIX mutation spectrum in haemophilia B patients from Jordan: identification of three novel mutations
Autor:
Dana Alhattab, Ahmad Magablah, Razan Mefleh, Abdelhalim Awidi, M. Dweiri, A. S. Fauori, Nazzal Bsoul
Publikováno v:
Haemophilia. 17:162-163